Thus, our case–control study reveals rs1048943/CYP1A1 as a histological subtype-specific variant for lung cancer in the East Indian population, potentially targeting personalised therapy and histology-specific drug designing for lung cancer patients. This evidence concerns the gene CYP1A1 and lung carcinoma.